Introduction
Due to social and global environmental changes, the aging population and the growing number of susceptible individuals (eg, patients with predisposing factors), the incidence of superficial mycosis has increased over the past few years causing health problems world-wide. 1, 2 Dermatomycosis usually manifests as itchy, sore skin rashes and tinea on the toes, the inner thighs or groin; leading to flaking and blistering of the affected area. Fungi may spread to the scalp or nails causing hair loss and thickened or deformed fingernails. The etiological agents behind dermatomycosis are mostly filamentous dermatophytes (eg, Microsporum spp., Trichophyton spp. or Epidermophyton spp.), however, several opportunistic yeast species such as Candida or Cryptococcus can invade keratinized tissues. 1, 3 In case of cutaneous candidiasis, the origin is mostly 696 rónavári et al endogenous as the causative agents (ie, Candida spp.) are the resident or transient members of the human dermal microflora. Cryptococcus neoformans can induce meningitis in immunocompromised patients, however, due to systemic dissemination of yeast cells in such patients, skin lesions may also appear. 4 In addition to this secondary variant, a primary form of cutaneous cryptococcosis has recently been identified, where the pathogen enters the body directly through skin injury. 5 Regardless of the distinct origins of Cr. neoformans infections, this pathogen can cause life-threatening systemic complications in the host. 4, 5 Therefore, there is an inevitable and urgent medical need to find novel and efficient agents to defeat opportunistic pathogens and cutaneous mycosiscausing species. To achieve this goal, an innovative, environmentally benign and economic approach is required.
A solution that fulfills these demands could be based on nanotechnology, since owing to the abundance of recent scientific advancements in this field, it is now possible to design and develop nano-sized structures with unique properties tailored for specific applications (eg, in optics, in electronics, in catalysis, and in household items, as well as in medicine). 6 In recent years, gold nanoparticles (AuNPs) and silver nanoparticles (AgNPs), 7 in particular, have been in the focus of increasing interest due to their simple synthesis and desirable biological activities (ie, antitumor, antibacterial, antiviral and antifungal effects). 8, 9 We have reported that the cytotoxic features of AgNPs can be exploited to kill p53 tumor suppressor-deficient 10 as well as multidrug-resistant cancer cells, 11 providing some further details to the mechanism of AgNP-induced antitumor actions. In recent years, several studies have also demonstrated that AgNPs, synthesized either by conventional chemical reduction methods, physical techniques or by different biological entities, exhibit potent inhibitory effects against Gram positive and Gram negative bacterial species and induce cytotoxicity in various pathogenic fungi. 8, 12 Green alternatives to harsh reducing chemicals and environmentally benign capping agents have also been developed to reduce the costs of nanoparticle production and to minimize the generation of hazardous wastes upon the synthetic procedures. 13 In a comprehensive study on AgNPs obtained by chemical reduction using coffee and green tea extracts, we proved the remarkable antimicrobial efficiency of such particles, 14 and we showed evidence that the green material used for AgNP synthesis can largely define the physical, chemical and biological characteristics of the produced nanomaterial. 14 Owing to widespread applications, there is an ever-growing demand for AgNPs and AuNPs, while the challenges of their economical, environmentally safe and sustainable production should also be addressed. A rapidly progressing area of nanobiotechnology is the microbe-assisted nanoparticle synthesis, 15 where bacterial strains, yeast-and alga-mediated reactions are exploited for nanoparticle generation. 16, 17 One such study demonstrated that the astaxanthin-containing green alga Chlorella vulgaris is a useful agent for gold nanoparticle synthesis. 18 Based on this observation we hypothesized that Phaffia rhodozyma (perfect state Xanthophyllomyces dendrorhous), a basidiomycetous red yeast with high astaxanthin content, 19 might also be a potential candidate for microbe-assisted nanoparticle synthesis. Therefore, the aim of this present study was to investigate the suitability of P. rhodozyma cell-free extract for the preparation of AgNPs and AuNPs. Since our synthesis method proved to be successful, the as-prepared nanoparticles were characterized, and a complex biological screening was carried out to determine their biological activity, where beside toxicity to human skin-derived cells, the antifungal efficiency of the bio-synthesized nanoparticles was also assessed with a special emphasis on inhibitory features against opportunistic pathogenic yeasts and dermatophytes.
Materials and methods

Preparation of P. rhodozyma cell-free extract
P. rhodozyma American Type Culture Collection (ATCC) 24203 cells grown on 2× yeast extract peptone dextrose (YPD; Sigma-Aldrich Co., St Louis, MO, USA) (2% D-glucose, 2% peptone, 1% yeast extract and 2% agar) plates at 22°C for 5 days were collected by cell scraper. Ten grams of wet weight biomass were suspended in 200 mL sterile distilled water and the cells were disrupted in Bead Beater (BioSpec Products, Inc., Bartlesville, OK, USA) using glass beads with 0.5-1 mm diameter. Cell debris was removed by centrifugation at 18,000 g for 15 min in Sorvall RC-5B centrifuge (Thermo Fisher Scientific, Waltham, MA, USA) at 4°C. The supernatant was filtered through 0.45 µm pore sized nitrocellulose membrane (Merck KGaA, Darmstadt, Germany). The filtrate was used as a reducing agent and stabilizer for the synthesis of nanoparticles.
synthesis of agNPs and auNPs
After optimization of the nanoparticle synthesis process, the following protocol was used. For preparation of AgNP, 90 mL cell-free extract (pH 6.7) was mixed with 10 mL of 1 M AgNO 3 suspension. Gold nanoparticles were synthesized similarly, by adding 10 mL 1 M HAuCl 4 solution to 90 mL cell-free extract. Both suspensions were constantly stirred using an orbital shaker at 22°C for 24 hours. Nanoparticles were pelleted by centrifugation for 15 min at 18,000 g in 
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antifungal activity of biosynthesized silver and gold nanoparticles Sorvall RC-5B centrifuge at 4°C then washed twice with sterile distilled water. The final colloid suspensions were characterized and stored at 4°C.
characterization of nanoparticles
The morphological features of the synthesized AgNPs and AuNPs were analyzed by transmission electron microscopy (TEM) using a FEI Tecnai G 2 20 microscope (FEI Corporate Headquarters, Hillsboro, OR, USA) at an acceleration voltage of 200 kV. The hydrodynamic particle size distribution of the samples was assessed by dynamic light scattering (DLS) analysis using a Zetasizer Nano Instrument (Malvern Instruments, Malvern, UK). The crystal structures were examined by X-ray powder diffraction (XRD), where the scans were performed with a Rigaku MiniFlex II powder diffractometer (Rigaku Corporation, Tokyo, Japan) using Cu Kα radiation. A scanning rate of 2° min -1 in the 20°-80° 2θ range was used. Finally, the optical properties of the obtained AuNPs and AgNPs were studied using an Ocean Optics 355 DH-2000-BAL ultraviolet-visible (UV-VIS) spectrophotometer (Halma PLC, Largo, FL, USA) in a 10-mm path length quartz cuvette. The absorbance spectra of nanoparticles were recorded within the range of 300-800 nm.
cell culture
HaCaT immortalized keratinocyte cell line from adult human skin was purchased from ATCC. HaCaT cells were maintained in Dulbecco's Modified Eagle's Medium (DMEM) containing 4.5 g/L glucose, supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 0.01% streptomycin and 0.005% ampicillin. Cells were cultured under standard conditions in a 37°C incubator at 5% CO 2 in 95% humidity.
cell viability and toxicity assays
MTT mitochondrial activity assay (Sigma-Aldrich) was performed to measure cell viability. HaCaT cells were seeded into 96 well plates (10,000/wells) and treated with either AgNPs or AuNPs, or with cisplatin in different concentrations on the following day. After 24-hour treatments cells were washed with phosphate buffered saline (PBS) and incubated with culture medium containing 0.5 mg/mL MTT reagent for 1 hour at 37°C. Formazan crystals were solubilized in DMSO and extinction was measured at 570 nm using a Synergy HTX plate reader (Thermo Fisher Scientific). Absorption corresponding to the untreated control samples was considered as 100%. MTT assays were performed at least three times using four independent biological replicates.
Cytotoxicity of the synthesized nanoparticles was assessed by crystal violet staining as well. For this, HaCaT cells were seeded into 24 well plates and were left to grow until they reached confluence. Then cell layers were treated with nanoparticles or with cisplatin for 24 hours. After each treatment, cells were washed three times with PBS and fixed using methanol:acetone 70:30 mixture. Fixed cells were then stained using 0.5% crystal violet dissolved in 25% methanol, washed with distilled water then air-dried. Plates were photographed, and crystal violet was solubilized using 400 µL 10% acetic acid. From each well, 100 µL solution was transferred to 96 well plates then absorbance was determined at 590 nm using a the HTX microplate reader.
screening of antifungal activity
The antifungal activity of the nanoparticles was tested against pathogenic yeasts as well as against various dermatophytes. The examined strains are listed in Table 1 .
First, agar diffusion assay was carried out as described previously. 20 Briefly, 5 µL of the synthesized AuNP or AgNP suspensions (5 mg/mL) were loaded onto the surface of the plates seeded by the test strains. The plates were incubated at 30°C and the inhibition zones were determined after 24 hours.
Anti-dermatophyte activity was tested on potato dextrose agar (PDA; VWR, Radnor, PA, USA) plates. Agar plugs of 3 mm diameter were cut from 4-day-old cultures and inoculated upside down onto the surface of PDA plates supplemented with AgNP (in 10 or 30 µg/mL concentration) or with AuNP (first in 10 or 30 µg/mL and later in 300 µg/mL concentrations). Subsequently, the plates were incubated for 4 days at 30°C and the diameter of the colonies was measured.
All experiments were carried out at least three times using three biological replicates.
Yeast viability assay
The number of colony forming units (CFU) was determined to assess the viability of nanoparticle-treated Cr. neoformans 
(HBSS) were exposed to either AgNP or AuNP in concentrations of 1, 5, 10, and 30 µg/mL for 24 hours at 30°C. After treatment, cells were washed and were resuspended in 1 mL sterile water. A tenfold dilution series was prepared and 25 µL aliquots from each dilution were spread onto YPD plates in triplicates. Non-treated cells were used as control. Plates were incubated at 30°C for 72 hours and the number of the colonies was counted. The experiments were carried out 3 times.
Following AgNP or AuNP treatments, the viability of Cr. neoformans cells was examined by calcein-AM assay using flow cytometry. Briefly, 4×10
6 cells were exposed to 5, 10 or 30 µg/mL AgNPs or to 10 and 30 µg/mL AuNPs in HBSS at 30°C for 24 hours. After the treatments, cells were washed with sterile distilled water, suspended in 200 µL HBSS supplemented with 10 µg/mL verapamil (Sigma-Aldrich) and were incubated for 20 min at 30°C to block efflux transporter activity. Subsequently, calcein-AM (Thermo Fisher Scientific) was added in 10 µM concentration and the suspensions were further incubated in the dark at 30°C for 3 hours. Cells were washed with HBSS and the fluorescent intensity was measured by flow cytometer (FlowSight ® , Amnis-EMD Millipore) using a 488-nm excitation laser.
The time-dependent effect of nanoparticle treatments was investigated by exposing 4×10 6 Cr. neoformans cells in 1 mL HBSS to AgNP or AuNP in 10 µg/mL concentrations at 30°C. After 1-, 3-, 10-and 24-hour treatments, aliquots of 100 µL each were taken, and after a washing step were re-suspended in 1 mL sterile water. Then tenfold dilution series was prepared and from each dilution 25 µL aliquots were spread onto the surface of YPD plates. Non-treated cells were used as control. The plates were incubated at 30°C for 72 hours and the number of the colonies was counted. The experiments were carried out three times, in three biological replicates.
Results
characterization of nanoparticles
Particle morphology and size of the synthesized AgNPs and AuNPs were determined by TEM image analysis. According to the obtained TEM micrographs, AgNPs were quasi-spherical, well separated from each other and minor polydispersity could be observed ( Figure 1A) . The average size of the AgNPs proved to be 4.1±1.44 nm. Gold particles were almost monodispersed, well separated and spherical with a narrow size distribution (2.22±0.7 nm). DLS measurements were also carried out to determine hydrodynamic particle sizes ( Figure 1B) . The average size of AgNPs was between 5 and 9 nm diameter, whereas the size of gold nanoparticles was around 4-7 nm. The formation of metal nanoparticles was ascertained by UV-VIS measurements ( Figure 1C ). The typical surface plasmon resonance (SPR) band of AgNPs appeared around 455 nm. UV-VIS spectra of AuNPs showed absorption peak maxima at 541 nm characteristic to SPR, which further supported the formation of metallic gold nanoparticles. In order to confirm the crystalline nature of the nanoparticles, XRD analysis was performed. The XRD pattern of the AgNP sample ( Figure 1D ) exhibited four identical diffraction peaks appearing at 2θ =38.4°, 44.4°, 64.7° and 77.5° corresponding to (111), (200), (220) and (311) planes of the face-centered cubic lattice structure of metallic silver 21 
Toxicity on human cells
We assessed the cell viability of human skin-derived keratinocyte HaCaT cells treated with biologically synthesized AgNPs and AuNPs. MTT assays revealed that the nanoparticles, both AgNPs and AuNPs, applied in 0-60 µg/mL concentrations, did not reduce the viability of HaCaT cells (Figure 2A ). On the other hand, treatments with the wellknown therapeutic agent cisplatin caused considerable cytotoxicity, since significant loss of keratinocyte metabolic activity was observed already at 5 µg/mL cisplatin concentration (Figure 2A) .
Cytotoxicity of AgNPs and AuNPs was analyzed by the crystal violet staining method ( Figure 2B ). AgNPs and AuNPs generated by P. rhodozyma cell-free extract were non-toxic to the applied human cells in the tested concentration range. Conversely, cisplatin proved to be significantly toxic to human HaCaT cells. These results indicate that these biogenic AgNPs and AuNPs exhibit no toxicity therefore both are biocompatible to human keratinocytes.
Efficiency against pathogenic yeasts
The antifungal activity of the prepared AgNPs and AuNPs was tested against various Candida and Cryptococcus species. AgNPs inhibited the growth of all the examined strains in agar diffusion assay except that of Candida tropicalis 
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antifungal activity of biosynthesized silver and gold nanoparticles ( Figure 3A) . Interestingly, Cr. neoformans was sensitive to AuNPs as well, whereas other species exhibited resistance against AuNPs ( Figure 3A) .
Since Cr. neoformans appeared susceptible to both nanoparticles, the antifungal effect of AgNPs and AuNPs was assessed more quantitatively on this particular strain. Hence, Cr. neoformans cells were subjected to different concentrations of AgNPs and AuNPs for 24 hours then cell viability was determined using colony forming assay ( Figure 3B ). Treatments with 1 µg/mL of either AgNPs or AuNPs already resulted in a significant loss of cell viability, whereas the number of viable Cr. neoformans cells dropped below the detectable level following 30 µg/mL of AuNP or AgNP administrations ( Figure 3B ).
To further test the viability of nanoparticle-treated Cr. neoformans cells, calcein-AM staining procedure was applied. As expected, increasing concentrations of either AgNPs or AuNPs gradually diminished the percentage of calcein-positive cells. After 10 µg/mL AgNP administration, approximately 50% of the cells were alive, while 83% of the examined cells were dead when AgNP concentration was elevated to 30 µg/mL ( Figure 3C) . A similar pattern was observed when yeast cells were exposed to AuNPs, since nanoparticle treatments in 30 µg/mL concentrations Figure 3C ). Time dependence of the nanoparticle-induced antifungal effect was also determined. For this purpose, Cr. neoformans cells were again subjected to 10 µg/mL AgNPs or AuNPs and after 1-, 3-, 10-and 24-hour treatments the number of the colonies was counted. Exposure to AgNPs for 1 hour caused a 50% decrease in the number of the CFU, but 10-hour treatments with either AgNPs or AuNPs reduced the number of viable cells below 10% ( Figure 3D ).
anti-dermatophyte activity
All the three examined dermatophyte species were sensitive to AgNP treatments in growth inhibition assay (Figure 4) . AgNPs in 30 µg/mL concentration induced significant inhibition of colony growth, as the diameters of the colonies were markedly smaller, indicating an approximately 80% growth inhibition for each strain (Figure 4 ). On the other hand, none of the dermatophyte species reacted to AuNPs, when applied in 10 or 30 µg/mL concentrations. Therefore, AuNP concentration was elevated up to 300 µg/mL but still no inhibition was detected (data not shown), indicating that AuNPs are not suitable for the growth inhibition of the examined cutaneous mycosis-causing dermatophyte fungi.
Discussion
Emerging problems associated with antibiotic-resistant microbes demanded new strategies to find novel antimicrobial agents. 23, 24 Due to their broad spectrum activity, silver-containing materials have been used as antiseptics and disinfectants for decades, 25 however the potential application of colloidal gold for medical purposes has only recently been recognized. 26 Physical and chemical methods are generally considered as standard approaches for nanoparticle preparation, nevertheless these procedures lead to the accumulation of environmentally hazardous wastes. 27 Furthermore, the presence of chemical residues within the nanoparticle colloid solutions limits their biomedical utilization. 28 Biological synthesis is regarded as an eco-friendly and costeffective alternative for the production of biocompatible 
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antifungal activity of biosynthesized silver and gold nanoparticles nanoparticles. 29 The numerous publications reporting either living microorganisms, plants or cell-free extracts for the synthesis of nanomaterials highlight this rapidly expanding field of bionanotechnology. 15, 30 In this study, we investigated the suitability of P. rhodozyma cell-free extract for AuNP and AgNP preparation, since this microbe contains an effective antioxidant, astaxanthin in high concentration, which promotes the formation of metal nanoparticles. 31 AgNPs and AuNPs were successfully synthesized and the biological activities of the as-prepared nanoparticles were subjected to complex analysis. AgNPs were effective against all the examined mycosis-causing fungal species, except for C. tropicalis. Most importantly, these biosynthesized silver particles were capable of inhibiting the growth of several opportunistic Candida or Cryptococcus species and were highly potent against filamentous Microsporum and Trichophyton dermatophytes. In addition, AgNPs were biocompatible, showing no cytotoxicity to human HaCat keratinocytes, which renders these biosynthesized AgNPs attractive candidates for further biomedical and pharmacological applications. It is also noteworthy that among the tested species only Cr. neoformans was susceptible to both AgNPs and AuNPs. We believe this is a relevant finding, since mainly antibacterial features of AuNPs have been demonstrated so far, [32] [33] [34] while the scientific literature is short on investigations into the potential antifungal feature of AuNPs. 35, 36 Importantly, apart from their capacity to inhibit Cr. neoformans, gold nanoparticles exerted no toxicity on human keratinocytes. These results emphasize the potential of such biosynthesized nanoparticles in topical dermatologic therapeutic strategies. Since cutaneous mycosis has the highest incidence among fungal infections, 1,2,37 costeffective, novel treatment modalities should be introduced into the related clinical practice. The symptoms can range from subclinical (eg, itching, rash), to serious inflammatory reactions (eg, blistering, scarring, alopecia), requiring distinct treatment regimens. Furthermore, the infective species can induce severe complications in immunocompromised individuals, including organ transplant, hematology and oncology patients where the infected area can manifest ulceration or even tissue necrosis. 3 The severity of these symptoms should be attenuated by complementary management using topical treatment approaches. We believe that biosynthesized metal nanoparticles could be implemented to improve the clinical outcome of cutaneous mycosis.
Conclusion
We found that the cell-free extract of P. rhodozyma is a suitable material for the synthesis of biogenic AgNPs and AuNPs. We demonstrated that these nanoparticles are potent against cutaneous mycosis-causing dermatophytes and opportunistic yeast species and are non-toxic to human keratinocytes. Considering our data in the context of the current clinical results, the biocompatibility to skin cells and the outstanding antifungal performance of our biosynthesized nanoparticles might be exploited during topical treatment of cutaneous mycosis or as a prophylactic treatment against the recurrence of the infection.
